ScholarIQanswers from OpenAlex & ORCID
Keith S. Kaye
ResearcherPublications, citations & collaboration network
Keith S. Kaye is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Keith S. Kaye have?
ScholarIQindexed works
Keith S. Kaye has 690 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Keith S. Kaye have?
ScholarIQcitation count
Keith S. Kaye has 34,745 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Keith S. Kaye?
ScholarIQh-index
Keith S. Kaye has an h-index of 96 in OpenAlex.
What is the i10-index of Keith S. Kaye?
ScholarIQi10-index
Keith S. Kaye has an i10-index of 356 in OpenAlex.
What is the ORCID of Keith S. Kaye?
ScholarIQorcid
The ORCID for Keith S. Kaye is on the source record.
What is the OpenAlex record for Keith S. Kaye?
ScholarIQopenalex
The OpenAlex for Keith S. Kaye is on the source record.
What are the most-cited papers on Keith S. Kaye?
ScholarIQmost cited works
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
David van Duin, Judith J. Lok, Michelle Earley, Eric Cober, Sandra S. Richter, Federico Pérez, Robert A. Salata, Robert C. Kalayjian, Richard Watkins, Yohei Doi, Keith S. Kaye, Vance G. Fowler, David L. Paterson, Robert A. Bonomo, Scott Evans, Antibacterial Resistance Leadership Group
Strategies to Prevent Surgical Site Infections in Acute Care Hospitals
Deverick J. Anderson, Keith S. Kaye, David C. Classen, Kathleen Meehan Arias, Kelly Podgorny, Helen Burstin, David P. Calfee, Susan Coffin, Erik R. Dubberke, Victoria J. Fraser, Dale N. Gerding, Frances A. Griffin, Peter Groß, Michael Klompas, Evelyn Lo, Jonas Marschall, Leonard A. Mermel, Lindsay E. Nicolle, David A. Pegues, Trish M. Perl, Sanjay Saint, Cassandra D. Salgado, Robert A. Weinstein, Robert A. Wise, Deborah S. Yokoe
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
Richard G. Wunderink, Yuko Matsunaga, Mari Ariyasu, Philippe Clevenbergh, Roger Echols, Keith S. Kaye, Marin H. Kollef, Anju Menon, Jason M. Pogue, Andrew F. Shorr, Jean‐François Timsit, Markus Zeitlinger, Tsutae Den Nagata
Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals
Jonas Marschall, Leonard A. Mermel, David C. Classen, Kathleen Meehan Arias, Kelly Podgorny, Deverick J. Anderson, Helen Burstin, David P. Calfee, Susan Coffin, Erik R. Dubberke, Victoria J. Fraser, Dale N. Gerding, Frances A. Griffin, Peter Groß, Keith S. Kaye, Michael Klompas, Evelyn Lo, Lindsay E. Nicolle, David A. Pegues, Trish M. Perl, Sanjay Saint, Cassandra D. Salgado, Robert A. Weinstein, Robert A. Wise, Deborah S. Yokoe
Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals
Evelyn Lo, Lindsay E. Nicolle, David C. Classen, Kathleen Meehan Arias, Kelly Podgorny, Deverick J. Anderson, Helen Burstin, David P. Calfee, Susan Coffin, Erik R. Dubberke, Victoria J. Fraser, Dale N. Gerding, Frances A. Griffin, Peter Groß, Keith S. Kaye, Michael Klompas, Jonas Marschall, Leonard A. Mermel, David A. Pegues, Trish M. Perl, Sanjay Saint, Cassandra D. Salgado, Robert A. Weinstein, Robert A. Wise, Deborah S. Yokoe